Recombinant Fibroblast Interferon and Immune Interferon for Treating Chronic Hepatitis B Virus Infection: Patients' Tolerance and the Effect on Viral Markers

Abstract

Journal Article Recombinant Fibroblast Interferon and Immune Interferon for Treating Chronic Hepatitis B Virus Infection: Patients' Tolerance and the Effect on Viral Markers Get access Jack Bissett, Jack Bissett Division of Infectious Diseases and Division of Gastroenterology, Department of Medicine, Stanford University, Stanford, California Please address requests for reprints to Dr. Jack Bissett, Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California 94305. Search for other works by this author on: Oxford Academic PubMed Google Scholar Mark Eisenberg, Mark Eisenberg Division of Infectious Diseases and Division of Gastroenterology, Department of Medicine, Stanford University, Stanford, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Peter Gregory, Peter Gregory Division of Infectious Diseases and Division of Gastroenterology, Department of Medicine, Stanford University, Stanford, California Search for other works by this author on: Oxford Academic PubMed Google Scholar William S. Robinson, William S. Robinson Division of Infectious Diseases and Division of Gastroenterology, Department of Medicine, Stanford University, Stanford, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Thomas C. Merigan Thomas C. Merigan Division of Infectious Diseases and Division of Gastroenterology, Department of Medicine, Stanford University, Stanford, California Search for other works by this author on: Oxford Academic PubMed Google Scholar The Journal of Infectious Diseases, Volume 157, Issue 5, May 1988, Pages 1076–1080, https://doi.org/10.1093/infdis/157.5.1076 Published: 01 May 1988 Article history Received: 23 June 1987 Revision received: 20 November 1987 Published: 01 May 1988